We report the natural course of Baker’s cysts following total knee arthroplasty (TKA) at short- and mid-term follow-up. In this prospective case series, 105 TKA patients were included. All patients who received surgery had a diagnosis of primary osteoarthritis and had preoperatively presented with a Baker’s cyst. Sonography and MRI were performed to evaluate the existence and the gross size of the cyst before TKA, and sonography was repeated at a mean follow-up time of 1.0 years (0.8 to 1.3; short-term) and 4.9 years (4.0 to 5.6; mid-term) after TKA. Symptoms potentially attributable to the Baker’s cyst were recorded at each assessment.Aims
Methods
The giant cell tumor of bone (GCT) is a locally aggressive intraosseous neoplasm, with an uncertain biological behavior, constituted of giant multinuclear cells spread over tumoral tissue with a nucleus presenting the same features of the ovoid and fusiform cells forming its stroma. The local recurrence of GCT is often observed, mainly in the first three years after treatment, giving a rate of recurrence ranging in 20 to 50% of cases. Further aggravating the recurrence is the fact that after the relapse, the patient often also presents metastases in other organs. The aim of this study was to identify and to characterize differentially expressed genes that can be used in the prognostic, treatment and understanding of this physiopathology. To identify novel genes differentially expressed in GCT, we have applied rapid subtractive hybridization (RaSH). Samples of GCT and normal tissues were obtained at Tumor Bank of Barretos Cancer Hospital. After RNA extraction and cDNA synthesis the samples were submitted to Rapid hybridization Subtraction (RaSH) methodology for subtractive libraries elaboration. The RaSH subtractive libraries reveals the presence of 619 different clones including both normal and tumor tissues were identified. Of these, 450 in tumor sample and 169 in control tissue. Four biomarkers candidates were selected for validation: ZAK, KTN1, NEB, and ROCK1 genes, whose functions are, related to cell cycle checkpoint, transport of organelles, cytoskeletal matrix and cell adhesions. The validation of selected differentially expressed genes was performed using real time PCR. The putative molecular markers found in this work may help to find the basis for a molecular comprehension of GCT, thus improving diagnosis, treatment and outcome for patients with this tumor.
Gorham syndrome is a rare disease of unknown cause. It is characterized by the massive bone destruction associated to bone angiomatosis. It was first described by Jackson in 1838. Gorham and Stout published their initial report in the fifth decade of the last century. The diagnosis depends on the exclusion of other diseases that cause bone lysis. The treatment has no uniformity between the oncologists, and different modalities of therapeutic procedures are being used as radiotherapy, biphosphonates, interferon and surgery. This case reports a man, 44 years old, caucasian farmer that had a progressive pain in the left groin one year ago. The pain was getting worst and migrated to the left hip. A pelvis X-ray revealed isquiatic lysis with total disappearing of the bone. The left hip presented diffuse lytic areas too. The clinical profile of the patient was good and it was discrepant when compared to the X-rays with bone destruction.The investigation was done with bone scintilography, MRI of the pelvis, computed tomography (CT) of abdomen and chest, blood analysis of PTH, calcium, phosphate, eletrophoresis of proteins, PCR, hepatic function, and two consecutive bone biopsies of the left hip and pelvis. All exams excluded metastatic or primary bone tumors. A multi-disciplinary team of clinical oncologists, endocrinologists, nephrologists excluded other neoplastic, metabolic and rare diseases as Hadju and Cheney acro-osteolysis, carpal and tarsal osteolysis, multicentric osteolysis with nephropaty, hereditary multicentric osteolysis, Joseph acro-osteolysis, Shinz acro-osteolysis, Faber disease and Winchester disease. A multidisciplinary meeting decided by the orthopaedic surgery and radiotherapy to relieve the pain and to achieve the pathological diagnosis. The girdlestone surgery was done and the histopathological analysis showed diffuse angiomatosis in the specimen, diagnosing Gorham syndrome. Gorham syndrome diagnosis depends on a tripod: clinical exclusion of other pathologys, image investigation and histopathology diagnosis. All three characteristics are primordial to the diagnosis of this pathology and a full investigation in a multidisciplinary level is necessary.
Our aim was to investigate vascular endothelial growth factor (VEGF) expression after lacerations of a meniscus in a rabbit model. Specimens of meniscus were examined using immunohistochemistry, enzyme-linked immunoassay and the reverse transcription polymerase chain reaction after one, two, five or ten weeks. In the periphery of the meniscus 90% of the lacerations had healed after five and ten weeks, but no healing was observed in the avascular area. Expression of VEGF protein and VEGF mRNA was found in the meniscus of both the operated and the contralateral sites but both were absent in control rabbits which had not undergone operation. The highest expression of VEGF was found in the avascular area after one week (p <
0.001). It then lessened at both the vascular and avascular areas, but still remained greater in comparison with the control meniscus (p <
0.05). Despite greater expression of VEGF, angiogenesis failed at the inner portion. These findings demonstrated the poor healing response in the avascular area which may not be caused by an intrinsic cellular insufficiency to stimulate angiogenesis.
One of the advantage in using unicondylar prosthesis seems to be the preservation of the bone stock, which allows most often easily revision to a total knee replacement if required. The purpose of the study was to compare the patients outcome after revision of unicondylar prosthesis with a group of patients who have received total knee replacement primarily.
The loss of full muscle activation contributes to weakness of the quadriceps muscle in patients with deficiency of the anterior cruciate ligament (ACL). We examined whether a deficit of voluntary activation (VA) of the quadriceps muscle can be reversed by reconstruction of the ACL and assessed its influence on muscle strength and clinical parameters. We evaluated 12 male subjects with an isolated tear of the ACL and 12 matched control subjects before operation and two years after reconstruction of the ACL. Assessment included measurements of isometric knee-extension torque at maximal voluntary contraction (MVC force), knee stability tests, the International Knee Ligament Standard Evaluation Form and the Tegner activity score. A sensitive method of twitch interpolation was used to quantify the VA and to calculate true muscle force. Before operation we found a deficit of VA on both the injured (mean ±SEM 74.9 ± 3.5%) and the uninjured side (74.6 ± 3.0%) in comparison with the control group (91 ± 0.9%). Two years after reconstruction of the ACL the VA improved significantly on both sides but remained less than that of the controls. Correlation analysis revealed an improvement of the VA in patients who returned to a higher level of activity. The deficit of true muscle force, however, persisted regardless of the clinical outcome and ligament stability.